Elcelyx Therapeutics Closes $20M Round
Elcelyx Therapeutics has raised $20 million in Series C financing. The company is a developer of products including an over-the-counter weight loss product and a treatment for Type 2 diabetes. Elcelyx has raised a total of $43 million since it was founded in 2010. GSM Fund led the latest round, which also included Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, and Technology Partners.
14 February 2013•3 mins read
